Keyphrases
Cost-effectiveness Analysis
100%
Quadrivalent
100%
Seasonal Influenza Vaccine
100%
Quadrivalent Influenza Vaccine
100%
Quadrivalent Vaccine
100%
Cost-effectiveness
80%
Elderly People
40%
Influenza Vaccination
40%
Pediatric
40%
Incremental Cost
40%
Trivalent Vaccine
40%
Clinical Risk
40%
Mathematical Model
20%
Wales
20%
High-risk Population
20%
General Practitioners
20%
Healthy children
20%
Vaccine Program
20%
Influenza A
20%
Seasonal Influenza Vaccination
20%
Influenza B
20%
Trivalent
20%
Health Benefits
20%
Pediatric Influenza
20%
Trivalent Inactivated Influenza Vaccine
20%
Live Attenuated Vaccine
20%
Target Choice
20%
Medicine and Dentistry
Health Care Cost
100%
Cost-Effectiveness Analysis
100%
Seasonal Influenza
100%
Influenza Vaccine
66%
Pediatrics
33%
Influenza Vaccination
22%
Triple Vaccine
22%
General Practitioner
11%
Influenza A
11%
Influenza B
11%
Population Risk
11%
Contraindication
11%
Live Vaccine
11%
Immunology and Microbiology
Influenza
100%
Influenza Vaccine
100%
Triple Vaccine
33%
Population Risk
16%
Live Vaccine
16%
Attenuated Vaccine
16%